Crossmark

Management of a human immunodeficiency virus case with discordant antiviral drug resistance profiles in cerebrospinal fluid compared with plasma: a case report

Crossref DOI link: https://doi.org/10.1186/s13256-022-03289-8

Published Online: 2022-02-15

Published Print: 2022-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Bang, Didi https://orcid.org/0000-0002-7490-5369
Fonager, Jannik

Johansen, Isik Somuncu
License Information

Text and Data Mining valid from 2022-02-15

Version of Record valid from 2022-02-15
More Information

Article History

Received: 13 March 2020

Accepted: 21 January 2022

First Online: 15 February 2022

Declarations

:

: This case report has been described in accordance with the ethical standards laid down in the “Declaration of Helsinki 1964” and its later amendments or comparable ethical standards. A written informed consent form was signed by the patient. Written informed consent for patient information and images to be published was provided by the patient.

: Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below